In the relentless battle against airborne viruses, researchers have developed a new spray coating to improve the antiviral ...

Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations ...

Global Antiviral Drugs Industry expected to hit worth US$ 89.6 Billion at CAGR of 3.9% from forecast period 2023 to 2033 ...

Antiviral Combination Therapies Market is valued approximately USD 40.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than $ over the forecast period 2020-2027.

CoV-2 highlights the need for new ways to fight them. RNA-targeting tools like CRISPR/Cas13 are powerful but inefficient in ...

Cidara Therapeutics already knew that Janssen planned to hand off its obligations to their flu prophylaxis candidate to ...

Antiviral drugs can be used for the treatment of influenza and the prevention of seasonal and post-exposure influenza. Four antiviral drugs are available for the prevention and treatment of ...

South Korea’s Hyundai Bioscience is preparing to start clinical trials of what it hopes could become the first antiviral ...

South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, announced on April 15 that it would carry out global ...

Researchers have revealed the regulatory mechanism of a specific protein, TRBP, that plays a key role in balancing the immune response triggered by viral infections in mammal cells. These findings ...

The BMA has received ‘many reports’ of ICBs considering decommissioning specialist Covid antiviral services and passing the ...